Inhibitory Effect of Curcumin on IMP Dehydrogenase, the Target for Anticancer and Antiviral Chemotherapy Agents
Authors:
- Yunkyung HanYHYunkyung Han
- Noriyuki YanakaNYNoriyuki Yanaka
- Norihisa KatoNKNorihisa Kato
- 23 January 2010
- journal article
- Published by Taylor & Francis in Bioscience, Biotechnology, and Biochemistry
- Vol. 74 (1) , 185-187
Abstract
Inosine monophosphate dehydrogenase (IMPDH), a rate-limiting enzyme in the de novo synthesis of guanine nucleotides, is a therapeutic target for anticancer and antiviral agents. Among the 15 different polyphenols examined, curcumin was found to have an inhibitory effect on the IMPDH activity in both a competitive and uncompetitive manner and to suppress the cellular GTP level in HT-29 colon carcinoma cells.Keywords
This publication has 16 references indexed in Scilit:
- Antiproliferative effects of AVN944, a novel inosine 5‐monophosphate dehydrogenase inhibitor, in prostate cancer cellsInternational Journal of Cancer, 2008
- Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discoveryMedicinal Research Reviews, 2007
- Inhibitory action of polyunsaturated fatty acids on IMP dehydrogenaseBiochimie, 2007
- (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesisWorld Journal of Gastroenterology, 2007
- Multiple molecular targets in cancer chemoprevention by curcuminThe AAPS Journal, 2006
- Molecular targets of dietary agents for prevention and therapy of cancerBiochemical Pharmacology, 2006
- In vitro anti-proliferative activities of ellagic acidThe Journal of Nutritional Biochemistry, 2004
- Nuclear factor‐κB and IκB kinase are constitutively active in human pancreatic cells, and their down‐regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosisCancer, 2004
- Targeted Disruption of the Inosine 5′-Monophosphate Dehydrogenase Type I Gene in MiceMolecular and Cellular Biology, 2003
- Recombinant human inosine monophosphate dehydrogenase type I and type II proteins: Purification and characterization of inhibitor bindingBiochemical Pharmacology, 1995